<SEC-DOCUMENT>0001493152-24-045338.txt : 20241114
<SEC-HEADER>0001493152-24-045338.hdr.sgml : 20241114
<ACCEPTANCE-DATETIME>20241114073009
ACCESSION NUMBER:		0001493152-24-045338
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20241114
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241114
DATE AS OF CHANGE:		20241114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABEONA THERAPEUTICS INC.
		CENTRAL INDEX KEY:			0000318306
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				830221517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15771
		FILM NUMBER:		241457201

	BUSINESS ADDRESS:	
		STREET 1:		6555 CARNEGIE AVE, 4TH FLOOR
		CITY:			CLEVELAND
		STATE:			OH
		ZIP:			44103
		BUSINESS PHONE:		646-813-4701

	MAIL ADDRESS:	
		STREET 1:		6555 CARNEGIE AVE, 4TH FLOOR
		CITY:			CLEVELAND
		STATE:			OH
		ZIP:			44103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PLASMATECH BIOPHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20140922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ACCESS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19960209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEMEX PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ABEO="http://abeonatherapeutics.com/20241114">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_ABEO_abeonatherapeutics.com_20241114 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20241114_20241114 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0000318306 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000004" name="dei:EntityCentralIndexKey">0000318306</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="abeo-20241114.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-11-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000318306</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-14</xbrli:startDate>
        <xbrli:endDate>2024-11-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_907_edei--DocumentType_c20241114__20241114_zqUjIahzqbm4"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PURSUANT
TO SECTION 13 OR 15(d) OF THE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of report (Date of earliest event reported): <b><span id="xdx_90D_edei--DocumentPeriodEndDate_c20241114__20241114_z7oJdK9gFWM5"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">November 14, 2024</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline"><span id="xdx_90D_edei--EntityRegistrantName_c20241114__20241114_zBzQJs6nVXE8"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000011" name="dei:EntityRegistrantName">ABEONA
THERAPEUTICS INC.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20241114__20241114_zBIDXJYwLFOj"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_90D_edei--EntityFileNumber_c20241114__20241114_zZC3ZcEXDTki"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000013" name="dei:EntityFileNumber">001-15771</ix:nonNumeric></span></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20241114__20241114_zTFIjBiUG077"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000014" name="dei:EntityTaxIdentificationNumber">83-0221517</ix:nonNumeric></span></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressAddressLine1_c20241114__20241114_zSGW1aX5H2m7"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000015" name="dei:EntityAddressAddressLine1">6555
Carnegie Ave</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressAddressLine2_c20241114__20241114_zcK7MxvwtFx8"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000016" name="dei:EntityAddressAddressLine2">4th Floor</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressCityOrTown_c20241114__20241114_zPMzH5m8SXYk"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000017" name="dei:EntityAddressCityOrTown">Cleveland</ix:nonNumeric></span>,
<span id="xdx_900_edei--EntityAddressStateOrProvince_c20241114__20241114_zJ7AFwfAg2f7"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000018" name="dei:EntityAddressStateOrProvince">OH</ix:nonNumeric></span> <span id="xdx_903_edei--EntityAddressPostalZipCode_c20241114__20241114_zOAJG7FYvEqf"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000019" name="dei:EntityAddressPostalZipCode">44103</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>(Address
of principal executive offices) (Zip Code)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_905_edei--CityAreaCode_c20241114__20241114_zVwDAJAkem2e"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000020" name="dei:CityAreaCode">(646)</ix:nonNumeric></span>
<span id="xdx_900_edei--LocalPhoneNumber_c20241114__20241114_zxZr2Cjtxgxg"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000021" name="dei:LocalPhoneNumber">813-4701</ix:nonNumeric></span><br/>
</span></b>(Registrant&#8217;s telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">N/A</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--WrittenCommunications_c20241114__20241114_zEvRf4x25GS5"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--SolicitingMaterial_c20241114__20241114_z4zF360BZOEl"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20241114__20241114_zuGczAZXlQph"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20241114__20241114_zACKtmq3Rz8k"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Each Class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--Security12bTitle_c20241114__20241114_zE5z6xy1id7k"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000026" name="dei:Security12bTitle">Common
    Stock, $0.01 par value</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--TradingSymbol_c20241114__20241114_zyAPDkzx98"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000027" name="dei:TradingSymbol">ABEO</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>The
    <span id="xdx_906_edei--SecurityExchangeName_c20241114__20241114_zmxvAW5UR6b9"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20241114__20241114_zzwmwDibbmE5"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 2.02.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results of Operations and Financial Condition.</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 14, 2024, Abeona Therapeutics Inc. (the &#8220;Company&#8221;) issued a press release entitled &#8220;Abeona Therapeutics Reports
Third Quarter 2024 Financial Results and Recent Corporate Updates&#8221; regarding its financial results for the quarter ended September
30, 2024. The full text of the press release is filed as. Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject
to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933,
as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9.01</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statements and Exhibits.</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release, dated November 14, 2024, entitled &#8220;Abeona Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates&#8221;</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona Therapeutics Inc.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant) </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ Joseph
    Vazzano</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Vazzano</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
November 14, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OdS1esjHpCKyCInodcsplnRHZjerT+ovW5VoGBiGe8+9QozEipa6QobTvMjhgHVTKYdQ4BUZzQW9I1tvUvC3wJu2jpVx/fsDM/IMemYaJpOzF3prqy2WKUgZyXGUTCCWqZzBfiuCTs/IXHWJxmlVgTIl7Jka1ugUv4eEg3qRofrdVx2RrSbj48J4kD+QxDKBHbXqSXy3kOeZCEb9BGLF9Gi8a/FyaDoSFhXWvs4O9H+DLwZdSow= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Abeona
Therapeutics<SUP>&reg;</SUP> Reports Third Quarter 2024 Financial Results and Recent Corporate Updates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>FDA
accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of April 29, 2025</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Company
makes significant progress toward potential commercialization of pz-cel in 2025; Builds momentum with payor discussions and target treatment
centers</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLEVELAND,
November 14, 2024 &ndash; Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the third quarter ended September
30, 2024, and recent corporate updates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;With
the acceptance of our Biologics License Application (BLA) resubmission for pz-cel, we are ramping up our commercial readiness efforts,
especially with respect to onboarding potential pz-cel treatment sites and continuing discussions with payors,&rdquo; said Vish Seshadri,
Chief Executive Officer of Abeona.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6pt 0 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Third
Quarter and Recent Progress</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pz-cel
for RDEB</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Abeona
                                            completed a Type A meeting in August 2024 where it aligned with the FDA on the content for
                                            the resubmission of the Company&rsquo;s BLA for pz-cel, its investigational first-in-class,
                                            autologous cell-based gene therapy currently in development for RDEB, including additional
                                            information to satisfy all Chemistry Manufacturing and Controls (CMC) requirements noted
                                            in the Complete Response Letter (CRL) issued in April 2024. The CRL required that certain
                                            CMC issues be addressed in the BLA resubmission, and did not identify any deficiencies related
                                            to the clinical efficacy or clinical safety data in the BLA. The FDA did not request any
                                            new clinical trials or clinical data to support the approval of pz-cel.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Also
                                            in August 2024, the Centers for Medicare and Medicaid Services (CMS) granted a product-specific
                                            procedure code ICD-10-PCS (International Classification of Diseases, 10th Revision, Procedure
                                            Coding System) for pz-cel. Also, as part of the Inpatient Prospective Payment System (IPPS)
                                            Final Rule for fiscal year 2025, CMS assigned Medicare reimbursement of pz-cel to Pre-Major
                                            Diagnostic Category, Medicare Severity Diagnosis Related Group 018 (Pre-MDC MS-DRG 018),
                                            which is among the highest available inpatient hospital reimbursement levels for cell and
                                            gene therapies. The favorable Medicare decisions support efficient hospital billing, reimbursement
                                            and patient access.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">In
                                            October 2024,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
                                            <FONT STYLE="font-weight: normal">resubmitted its BLA for pz-cel to the FDA, seeking approval
                                            of pz-cel as a potential new treatment for patients with </FONT>RDEB.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
                                            in October 2024, Abeona entered into a lease agreement for additional facility space in Cleveland,
                                            Ohio to enable manufacturing capacity expansion beyond the current planned manufacturing
                                            footprint.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
                                            in October 2024, the United States Patent and Trademark Office issued a new patent (U.S.
                                            Patent No. 12,110,504) (&ldquo;the &lsquo;504 Patent&rdquo;) and allowed the claims of a
                                            second patent (based on U.S. Patent Application No. 16/066,253) that is expected to issue
                                            in the coming weeks. Both patents are entitled &ldquo;Gene Therapy for Recessive Dystrophic
                                            Epidermolysis Bullosa Using Genetically Corrected Autologous Keratinocytes,&rdquo; and include
                                            claims that cover the use of pz-cel for the treatment of RDEB. The &lsquo;504 Patent has
                                            an expiration date of January 3, 2037, subject to any applicable patent term extension.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            November 2024, the FDA accepted for review the resubmission of Abeona&rsquo;s pz-cel BLA
                                            and set a PDUFA target action date of April 29, 2025.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            preparation for potential commercialization, Abeona continues to make progress on several
                                            key initiatives, including onboarding high-volume epidermolysis bullosa treatment centers
                                            in the U.S. for pz-cel treatment, engaging payers to ensure patient access, and educating
                                            key stakeholders.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            preparation for potential pz-cel launch, Abeona has hired and trained personnel to support
                                            commercialization, manufacturing, supply chain and quality.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pipeline
and partnered programs</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            July 2024, Abeona announced a non-exclusive agreement with Beacon Therapeutics, under which
                                            Beacon Therapeutics will evaluate Abeona&rsquo;s patented AAV204 capsid for its potential
                                            use in AAV gene therapies for select ophthalmology indications.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            October 2024, Ultragenyx participated in a successful pre-BLA meeting with the FDA during
                                            which Ultragenyx aligned on the details of its BLA for partnered program UX111 AAV gene therapy
                                            for Sanfilippo syndrome type A (MPS IIIA) that is expected to be filed around the end of
                                            2024.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 8.3pt 0 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6pt 0 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Third
Quarter Financial Results and Cash Runway Guidance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6pt 0 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6pt 0 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash,
cash equivalents, short-term investments and restricted cash totaled $110.0 million as of September 30, 2024. As of June 30, 2024, cash,
cash equivalents, short-term investments and restricted cash totaled $123.0 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6pt 0 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6pt 0 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
estimates that its current cash and cash equivalents, short-term investments and restricted cash, as well as its credit facility, are
sufficient resources to fund operations into 2026, before accounting for any potential revenue from commercial sales of pz-cel, if approved,
or proceeds from the sale of a Priority Review Voucher (PRV), if awarded by the FDA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6pt 0 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6pt 0 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses for the three months ended September 30, 2024 were $8.9 million, compared to $7.1 million for the same period
of 2023. General and administrative expenses were $6.4 million for the three months ended September 30, 2024, compared to $4.2 million
for the same period of 2023. The increase in general and administrative expenses is primarily due to commercial and launch preparation
costs. Net loss for the third quarter of 2024 was $30.3 million, including a $15.2 million loss resulting from the quarterly remeasurement
of the fair value of warrant and derivative liabilities. In the third quarter of 2023, net loss was $11.8 million, including a $1.1 million
loss resulting from the quarterly remeasurement of the fair value of warrant liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6pt 0 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6pt 0 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conference
Call Details</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6pt 0 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will host a conference call and webcast on Thursday, November 14, 2024, at 8:30 a.m. ET, to discuss the quarter results. To access
the call, dial 877-545-0320 (U.S. toll-free) or 973-528-0002 (international) and Entry Code: 500590 five minutes prior to the start of
the call. A live, listen-only webcast and archived replay of the call can be accessed on the Investors &amp; Media section of Abeona&rsquo;s
website at <U>https://investors.abeonatherapeutics.com/events</U>. The archived webcast replay will be available for 30 days following
the call.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Abeona Therapeutics</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT><BR>
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Prademagene
zamikeracel (pz-cel) is Abeona&rsquo;s investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for
recessive dystrophic epidermolysis bullosa. The Company&rsquo;s fully integrated cell and gene therapy cGMP manufacturing facility served
as the manufacturing site for pz-cel used in its Phase 3 VIITAL&trade; trial, and is capable of supporting commercial production of pz-cel
upon FDA approval. The Company&rsquo;s development portfolio also features AAV-based gene therapies for ophthalmic diseases with high
unmet medical need. Abeona&rsquo;s novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of
devastating diseases. For more information, visit <U>www.abeonatherapeutics.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6pt 0 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">This press release contains
certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties. We have attempted to identify forward-looking
statements by such terminology as <FONT STYLE="font-weight: normal"><I>&ldquo;</I></FONT><I>may,&rdquo; &ldquo;will,&rdquo; &ldquo;believe,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;potential,&rdquo; and similar words and expressions (as
well as other words or expressions referencing future events, conditions or circumstances), which constitute and are intended to identify
forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a result
of various important factors, numerous risks and uncertainties, including but not limited to, the timing and outcome of the FDA&rsquo;s
review of our BLA resubmission for pz-cel; the FDA&rsquo;s grant of a Priority Review Voucher upon pz-cel approval; continued interest
in our rare disease portfolio; our ability to enroll patients in clinical trials; the outcome of future meetings with the FDA or other
regulatory agencies, including those relating to preclinical programs; the ability to achieve or obtain necessary regulatory approvals;
the impact of any changes in the financial markets and global economic conditions; risks associated with data analysis and reporting;
and other risks disclosed in the Company&rsquo;s most recent Annual Report on Form 10-K and subsequent periodic reports filed with the
Securities and Exchange Commission. The Company undertakes no obligation to revise the forward-looking statements or to update them to
reflect events or circumstances occurring after the date of this press release, whether as a result of new information, future developments
or otherwise, except as required by the federal securities laws.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><I><B>&nbsp;</B></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
and Media Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greg
Gin<BR>
VP, Investor Relations and Corporate Communications<BR>
Abeona Therapeutics</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ir@abeonatherapeutics.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABEONA
THERAPEUTICS INC. AND SUBSIDIARIES<BR>
</B>Condensed Consolidated Statements of Operations and Comprehensive Loss</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
in thousands, except share and per share amounts)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">For the three months</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">ended September 30,</P></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">For the nine months</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">ended September 30,</P></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Revenues:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 36%; text-align: left">License and other revenues</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">3,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Royalties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,605</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,941</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,148</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,366</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,712</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">General and administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,404</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,156</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,173</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,174</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Gain on operating lease right-of-use assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,065</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">15,345</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,334</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">47,539</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">37,426</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15,345</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,334</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(47,539</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(33,926</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,189</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">593</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,223</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,374</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,102</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(105</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,126</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(309</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Change in fair value of warrant and derivative liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15,156</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,101</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,530</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,465</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other income</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">145</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">111</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">531</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,729</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net Loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(30,269</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(11,836</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(54,441</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(37,597</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Basic and diluted loss per common share</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.63</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.48</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1.41</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1.89</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding - basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">48,081,758</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">24,797,564</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">38,504,273</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">19,942,613</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other comprehensive income (loss):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Change in unrealized gains (losses) related to available-for-sale debt securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(33</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(18</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Foreign currency translation adjustments</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">29</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">29</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Comprehensive loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(30,219</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(11,840</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(54,459</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(37,567</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABEONA
THERAPEUTICS INC. AND SUBSIDIARIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
Consolidated Balance Sheets</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
in thousands, except share and per share amounts)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September 30, 2024</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2023</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; width: 60%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">15,726</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">14,473</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Short-term investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">93,975</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,753</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">338</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">338</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Other receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,613</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,444</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,005</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">729</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">112,657</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">55,737</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,058</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,533</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating lease right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,789</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,455</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Other assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">88</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">277</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">120,592</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">64,002</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,789</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,858</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,210</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,985</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Current portion of long-term debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,444</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Current portion of operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,057</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">998</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Current portion payable to licensor</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,921</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,580</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,422</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,422</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Long-term operating lease liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,402</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,402</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Long-term debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,206</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Warrant liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">38,789</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">31,352</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left">Total liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,819</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,176</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Commitments and contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stockholders&rsquo; equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Preferred stock - $0.01 par value; authorized 2,000,000 shares; No shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Common stock - $0.01 par value; authorized 200,000,000 shares; 43,404,706 and 26,523,878 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">434</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">265</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">849,388</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">764,151</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(803,965</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(749,524</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accumulated other comprehensive loss</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(84</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(66</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">45,773</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">14,826</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">120,592</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">64,002</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !Z 5X# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?RO_\
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MPV8UHU:>-P^"=.='!XS"5JT'.7L?;TX59TJK=.'YG?M3? >36/VSM0G\._\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPV-Q]7"*GB,+@.1XZM4I03J8"=*@XXGEJU9\^%Y^>2E&4)?-'[;G_!0_XG?
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M#,:\+*E0HPBYPE5C?^EGX"_M/? ;]J#0]9\2_ +XG>%_B?H7AS6/^$?U^_\
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MX!/I7S8G[77[/LG[1EQ^R7%\0;:3]H2TT,>);CX<C0/%XN8]!.AV_B3^T/\
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MM-"U6!.L_P""0?["B_L1_LMZ1;^*]'ATWXX_&--,\??&)CY N]"N&M9!X/\
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M/_!-GX18/IK#@_@1\?P1^!'KU K\AOVB-=_X*+?LX?M7^&?^"H'Q/_8_T_\
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MOQ=-UZ:K8;%Y?B_;8'$8;$4I5:-:C/#*,J56<8RIM0</?S/PE\-L3EF,PO\
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MIEYI6C>-="CDOK2#QMI>J7FB37,NEZIH.LBPU/3_ .ADR\D!&;!P2N&QSCD
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MK4<)2IX>A'&YG@LSRK$9C5I4*5.C'$XZGB,5*G3BJF(K-<[^1CX5Y/@YUO[
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M_-<;A*.+I.5'$K!3PU2M0E.C[:$9R;\ZGX5Y+5QN QN>9[QGQ5_9F-P^98'
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0B@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>abeo-20241114.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaeESbP9z5Z8eekhvWBwbUm6PyUuCv2HNyufXLAWodcG -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ABEO="http://abeonatherapeutics.com/20241114" elementFormDefault="qualified" targetNamespace="http://abeonatherapeutics.com/20241114">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://abeonatherapeutics.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="abeo-20241114_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="abeo-20241114_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>abeo-20241114_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>abeo-20241114_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://abeonatherapeutics.com/role/Cover" xlink:href="abeo-20241114.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://abeonatherapeutics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46183119995664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 14, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 14,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ABEONA
THERAPEUTICS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000318306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-0221517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6555
Carnegie Ave<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">4th Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cleveland<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">44103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(646)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">813-4701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABEO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M;QA3:?+>628_CKE>VRS] 0K0?6%J$B:K)Q47/%EHC:-77?NWP5=FKYB2B*]
MR+WN@*[>OXGO!T8E^=OO4AEXE\XW-YS!0V!/@.,KI<S;P+Y0%_^'#/X#4$L#
M!!0    ( ,0[;EF?H!OPL0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;
M,!#^*T(_8&YB:N*1&+9 8;"-0O-A7Y58=@1Z\62Y<_KKI[-L)VEU9=V'L<VA
MR=T]NKM'=R>9KEMWDOSAR+DCO9*ZW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;
M)VUC.2M;<%(R6=[<9(EB0M-BK3MUIUQ+#J;3;D-O:%*L*Z//EI0&@U_*%">/
M3&[HEDFQMV)8RY20IV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O
M_;C\&3!IK5>%E#/!)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_
M/LG>V)+;.<V"3J9B+7D%=*RHC_#K3), Z)Q17B@%JXUF X?)8Q1\V .7\@%:
M^*VZBMU7)/3B4PEM(+#52?2$1C&$"0K$OXP68E^$O?VML*01C\9][/QN]*!_
M[XSC]Y97HA_TOIKS8]$7>'36-/+T08I:*Q[V_LL)BS6;_,C16/'DL\&D'+R!
M6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<
M'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72
M[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'
M')XC=\,31S"?@,41P+ \& /,)WAA>?ZG_:S0_00,X[:*(BO49X7Z!*\8LAT^
M6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]
M?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1
M/,<0F,7XC&894IT,/O'^8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\E
MTWLJ.?]74_P$4$L#!!0    ( ,0[;EF7BKL<P    !,"   +    7W)E;',O
M+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +
M&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P
M6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,
M-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4
M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ Q#MN6:K$(A8S 0  (@(   \
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M4$L! A0#%     @ Q#MN66:J[?;N    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ Q#MN69E<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " #$.VY9#P]>^V($   ;$0  &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ Q#MN69^@&_"Q @  X@P
M  T              ( !I0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #$
M.VY9EXJ[',     3 @  "P              @ &!#P  7W)E;',O+G)E;'-0
M2P$"% ,4    " #$.VY9JL0B%C,!   B @  #P              @ %J$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ Q#MN620>FZ*M    ^ $  !H
M             ( !RA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ Q#MN6660>9(9 0  SP,  !,              ( !KQ(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ^1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abeonatherapeutics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>abeo-20241114.xsd</File>
    <File>abeo-20241114_lab.xml</File>
    <File>abeo-20241114_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "ABEO",
   "nsuri": "http://abeonatherapeutics.com/20241114",
   "dts": {
    "schema": {
     "local": [
      "abeo-20241114.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "abeo-20241114_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "abeo-20241114_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://abeonatherapeutics.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-14",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-14",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001493152-24-045338-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-045338-xbrl.zip
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M<S@?,9-W<5 3N"RFDL_V:81%2OYR6#7F?P:[%2+'IT70/PN'NCV@"\K.U[5
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MT/N'Y)+&@Q"I=7X T6S:\:A$ <+1=M:'AE#[!.,JR2*<EEZNQ+:LHWD6K6M
M0+LZ)(8P*% @=R L98!BI@CQ"LR_".;#<&DH_<!B6+6C4LL"!$7WUH>)U'N!
M9+;EO.4:GG%@J;.;LCUFZ_NS@"X(4'K,&7=M2WD+%$\ST"7-DWPOGZ>[V6Y6
MA%L:9TI<L0&94TSHY4&P )C2&2AE2.I0*?32\^HN <WE0XQ@<W296P+L)ML4
MM#4!D6 U!M!PT!;/E'HA8B9&)H[3.8W)[F>R!]MEZ-PR =AL0Z&) J+"[@S
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M>[4]G TJO2!C6K4"<Y"%AXOAK0\6&2#7,S+$)R;%PNJ6WW'VDM (7C)#<B_
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M.Y*?.+#4-89D?0X)'&RR=S_=&LMC>S:2QM%($.^OO]TSDBV_P"*VL<%;=4[
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MCM(!@L%NA]R&#E- =,!EA-\'C*I@>-$ 4=@@B VE@H?D\AEW6Z$OE:1/1-%
M MSX+/.%_IU6(5]PVO4$\+%-:B DN\(?&*/W-4#K^1PD7/08ET #)4S)9U^
MDVU:Q^10O?JB1KXT,A>WG_&SHY3:^*''[1Z(?D)= ?1!U/?@#"B1>4^Y0UN
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M;7J+Z85T,/;W;"0'ULJ"XL6L$;@[/?"A,BKWH&N<=1VO[E>3@<_5F5;?"T1
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MFR(_DBLJ@]W\N>$?GS]_;B73X%;/OA_.KR_^.L,?_FA^N3K[?U!+ P04
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M4VXM+CDAL0EYC?7A[M6Y\M0^JO-M9+J'OK&W87^ESI])G?_QV>VIG9A#5I-
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M:_>TPO\!4$L! A0#%     @ Q#MN630J@E<N P   0P  !$
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7;5!+!08     !0 % #8!  !R2      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="abeo-20241114.xsd" xlink:type="simple"/>
    <context id="AsOf2024-11-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000318306</identifier>
        </entity>
        <period>
            <startDate>2024-11-14</startDate>
            <endDate>2024-11-14</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-11-14" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-11-14" id="Fact000004">0000318306</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-11-14" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-11-14" id="Fact000010">2024-11-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-11-14" id="Fact000011">ABEONA THERAPEUTICS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-11-14" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-11-14" id="Fact000013">001-15771</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-11-14" id="Fact000014">83-0221517</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-11-14" id="Fact000015">6555 Carnegie Ave</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-11-14" id="Fact000016">4th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-11-14" id="Fact000017">Cleveland</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-11-14" id="Fact000018">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-11-14" id="Fact000019">44103</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-11-14" id="Fact000020">(646)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-11-14" id="Fact000021">813-4701</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-11-14" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-11-14" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-11-14" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-11-14" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-11-14" id="Fact000026">Common     Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-11-14" id="Fact000027">ABEO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-11-14" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-11-14" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
